{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:30:32Z","timestamp":1782862232470,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ejphar.2012.07.024","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T04:57:08Z","timestamp":1342760228000},"page":"292-296","source":"Crossref","is-referenced-by-count":22,"title":["Effect of exendin (exenatide)\u2014GLP 1 receptor agonist on the thyroid and parathyroid gland in a rat model"],"prefix":"10.1016","volume":"691","author":[{"given":"Deepti","family":"Bulchandani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish S.","family":"Nachnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Herndon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad H.","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana A.","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leland","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.07.024_bib1","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1210\/endo.143.8.8973","article-title":"Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells","volume":"143","author":"Abraham","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2012.07.024_bib2","first-page":"1970","article-title":"Exenatide and rare adverse events","volume":"358","author":"Ahmad","year":"2008","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.ejphar.2012.07.024_bib3","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2012.07.024_bib4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/en.2009-1197","article-title":"Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor","volume":"151","author":"Ban","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2012.07.024_bib5","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2012.07.024_bib6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Bjerre Knudsen","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2012.07.024_bib7","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/en.2010-0115","article-title":"Minireview: update on incretin biology: focus on glucagon-like peptide-1","volume":"151","author":"Brubaker","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2012.07.024_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.biocel.2005.07.011","article-title":"Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus","volume":"38","author":"De Leon","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2012.07.024_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.29.02.06.dc05-2043","article-title":"Exenatide (exendin-4)-induced pancreatitis: a case report","volume":"29","author":"Denker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2012.07.024_bib10","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","article-title":"Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells","volume":"268","author":"Goke","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.07.024_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"Korner","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2012.07.024_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-5793(96)00895-2","article-title":"Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1","volume":"393","author":"Lamari","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2012.07.024_bib13","unstructured":"Liraglutide (Package insert Accessed from Drug facts and comparisons on line, 2008 \u3008http:\/\/www.victoza.com\/pdf\/Victoza_ComboPI_5.24.pdf\u3009 (accessed 30.12.10)."},{"key":"10.1016\/j.ejphar.2012.07.024_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/pr.55.1.6","article-title":"International Union of Pharmacology. XXXV. The glucagon receptor family","volume":"55","author":"Mayo","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2012.07.024_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00125-009-1515-4","article-title":"Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas","volume":"53","author":"Nachnani","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2012.07.024_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","article-title":"Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients","volume":"36","author":"Nauck","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2012.07.024_bib17","unstructured":"Parola, A., 2009. FDA Advisory Committee Non-Clinical Briefing Document. Pharmacology\/Toxicology Review of Thyroid C-cell Tumors in Rats and Mice, in: Dept. DHHS, PHS, Food and Drug Administration, Center for Drug Evaluation and Research, \u3008http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/cder08.html#EndocrinologicMetabolic\u3009, pp. 14\u201318."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2012.07.024_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.13.S1.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus","volume":"13","author":"Rodbard","year":"2007","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ejphar.2012.07.024_bib21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","article-title":"Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure","volume":"12","author":"Sokos","year":"2006","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2012.07.024_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0360-3016(88)90357-4","article-title":"Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme","volume":"15","author":"Ward","year":"1988","journal-title":"Int. J. Radiat. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912006176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912006176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T10:02:46Z","timestamp":1642845766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912006176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":20,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0014299912006176"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.07.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}